<DOC>
	<DOC>NCT01130324</DOC>
	<brief_summary>The purpose of this registry is to evaluate the outcome of pregnancy in women exposed to VIBATIV at any time during pregnancy. There are no mandated physician visits for the registry.</brief_summary>
	<brief_title>VIBATIV Pregnancy Registry</brief_title>
	<detailed_description />
	<mesh_term>Telavancin</mesh_term>
	<criteria>Female patients who were exposed to VIBATIV at any time during pregnancy Outcome of pregnancy is unknown at the time of enrollment</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>VIBATIV</keyword>
	<keyword>telavancin</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Registry</keyword>
</DOC>